Host-mediated resolution of inflammation in periodontal diseases (Q36362712)

13 August 2017

1 reference

title

Host-mediated resolution of inflammation in periodontal diseases (English)

1 reference

13 August 2017

0 references

1

Alpdogan Kantarci

1 reference

13 August 2017

3

Thomas E Van Dyke

1 reference

13 August 2017

2

Hatice Hasturk

1 reference

13 August 2017

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

40

1 reference

13 August 2017

page(s)

144-163

1 reference

Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Disodium chlodronate prevents bone resorption in experimental periodontitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Targeting cytokines in autoimmunity: new approaches, new promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Efficacy of Alendronate in Adults with Cystic Fibrosis with Low Bone Density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Effect of neutrophil apoptosis on monocytic cytokine response to Porphyromonas gingivalis lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Biologic effects and basic science of a novel immune-modulation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Matrix metalloprotease inhibitors: design from structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

TNF-blocking therapies: an alternative mode of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Anti-TNF therapy and malignancy - a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Effect of short-term treatment with pravastatin on cytokines and cytokine receptors in patients with chronic heart failure due to ischemic and nonischemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Essential fatty acids as possible mediators of the actions of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Is obesity an inflammatory condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates antiadhesive properties of 2-(Acetyloxy)benzoic acid 3-(nitrooxymethyl)phenyl ester (NCX-4016) (NO-aspirin) on neutrophil-endothelial cell adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Serious infections associated with anticytokine therapies in the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Inflammatory resolution: new opportunities for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The effect of spironolactone on experimental periodontitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The Contribution of Interleukin‐1 and Tumor Necrosis Factor to Periodontal Tissue Destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The role of lipopolysaccharide in infectious bone resorption of periapical lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

A Histopathological Investigation on the Effect of Systemic Administration of the Bisphosphonate Alendronate on Resorptive Phase Following Mucoperiosteal Flap Surgery in the Rat Mandible

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Clinical, pathological and immunological aspects of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Immune processes in periodontal disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Selective COX-2 inhibitors and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Effect of tranilast on matrix metalloproteinase-1 secretion from human gingival fibroblasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Matrix metalloproteinase inhibitors as anticancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Lipoxins: revelations on resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Regulation of matrix biology by matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Periodontal diseases: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Periodontitis decreases the antiatherogenic potency of high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Periodontal infections and atherosclerosis: mere associations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Alendronate treatment of naturally-occurring periodontitis in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Host response modulation in the management of periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Different results of plasma 6-keto-prostaglandin F1 alpha measurements utilizing two antisera with apparently similar specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Adverse effects of COX-2 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

TIMP-2: an endogenous inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

New cytokine therapeutics for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Contrasting effects of an aminobisphosphonate, a potent inhibitor of bone resorption, on lipopolysaccharide-induced production of interleukin-1 and tumour necrosis factor alpha in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Modulation of TNF-alpha gene expression by IFN-gamma and pamidronate in murine macrophages: regulation by STAT1-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Suppression of alveolar bone resorption by etidronate treatment for periodontal disease: 4- to 5-year follow-up of four patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Biology of inflammation in Crohn's disease: mechanisms of action of anti-TNF-a therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The mode of action of aspirin and similar compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The mechanism of action of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The potential use of MMP inhibitors to treat CNS diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

Effects of a bisphosphonate on experimental periodontitis in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

The effect of interleukin-11 on the progression of ligature-induced periodontal disease in the beagle dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00145.X

10.1111/J.1600-0757.2005.00145.X

21 January 2018

Identifiers

DOI

1 reference

release_urk3bf6adras3of6ntb7j23cue

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/urk3bf6adras3of6ntb7j23cue

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference